TOL-463 Phase 2 Study for Vaginitis
- First Posted Date
- 2016-08-15
- Last Posted Date
- 2018-03-09
- Lead Sponsor
- Toltec Pharmaceuticals, LLC
- Target Recruit Count
- 106
- Registration Number
- NCT02866227
- Locations
- 🇺🇸
University of Washington - Harborview Medical Center - Center for AIDS and STD, Seattle, Washington, United States
🇺🇸University of Alabama at Birmingham School of Medicine- Infectious Disease, Birmingham, Alabama, United States
© Copyright 2025. All Rights Reserved by MedPath